Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
|
15.10.2025 13:41:06
|
Abbott Laboratories Q3 Profit Inline With Estimates
(RTTNews) - Abbott Laboratories (ABT) released earnings for third quarter in line with the Street estimates.
The company's earnings totaled $1.644 billion, or $0.94 per share. This compares with $1.646 billion, or $0.94 per share, last year.
Excluding items, Abbott Laboratories reported adjusted earnings of $2.278 billion or $1.30 per share for the period.
Analysts on average had expected the company to earn $1.3 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 6.9% to $11.369 billion from $10.635 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings: $1.644 Bln. vs. $1.646 Bln. last year. -EPS: $0.94 vs. $0.94 last year. -Revenue: $11.369 Bln vs. $10.635 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
| Abbott Laboratories | 108,46 | 0,57% |
|